EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:132274 - (14S,15R)-EET

ChEBI IDCHEBI:132274
ChEBI Name(14S,15R)-EET
Stars
ASCII Name(14S,15R)-EET
DefinitionA 14,15-EET in which the epoxy moiety has 14S,15R-configuration.
Last Modified22 June 2016
SubmitterSteve
DownloadsMolfile
FormulaC20H32O3
Net Charge0
Average Mass320.473
Monoisotopic Mass320.23514
SMILESCCCCC[C@H]1O[C@H]1C/C=C\C/C=C\C/C=C\CCCC(=O)O
InChIInChI=1S/C20H32O3/c1-2-3-12-15-18-19(23-18)16-13-10-8-6-4-5-7-9-11-14-17-20(21)22/h4,6-7,9-10,13,18-19H,2-3,5,8,11-12,14-17H2,1H3,(H,21,22)/b6-4-,9-7-,13-10-/t18-,19+/m1/s1
InChIKeyJBSCUHKPLGKXKH-KZTFMOQPSA-N
Species of MetaboliteComponentSourceComments
Mus musculus (ncbitaxon:10090) - PubMed (12840027)
Roles Classification
Chemical Roles:
Bronsted acid  A molecular entity capable of donating a hydron to an acceptor (Brønsted base).
Bronsted acid  A molecular entity capable of donating a hydron to an acceptor (Brønsted base).
Bronsted acid  A molecular entity capable of donating a hydron to an acceptor (Brønsted base).
Bronsted acid  A molecular entity capable of donating a hydron to an acceptor (Brønsted base).
Biological Roles:
mouse metabolite  Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
metabolite  Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
metabolite  Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
Applications:
platelet aggregation inhibitor  A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
anti-inflammatory drug  A substance that reduces or suppresses inflammation.
platelet aggregation inhibitor  A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
anti-inflammatory drug  A substance that reduces or suppresses inflammation.
ChEBI Ontology
Outgoing Relation(s)
(14S,15R)-EET (CHEBI:132274) is a 14,15-EET (CHEBI:34157)
(14S,15R)-EET (CHEBI:132274) is conjugate acid of (14S,15R)-EET(1−) (CHEBI:131964)
(14S,15R)-EET (CHEBI:132274) is enantiomer of (14R,15S)-EET (CHEBI:132275)
Incoming Relation(s)
(14S,15R)-EET(1−) (CHEBI:131964) is conjugate base of (14S,15R)-EET (CHEBI:132274)
(14R,15S)-EET (CHEBI:132275) is enantiomer of (14S,15R)-EET (CHEBI:132274)
IUPAC Name 
(5Z,8Z,11Z)-13-[(2S,3R)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoic acid
Synonyms  Source
(14S,15R)-EpETrEChEBI
(14S,15R)-epoxy-(5Z,8Z,11Z)-eicosatrienoic acidChEBI
(14S,15R)-epoxy-(5Z,8Z,11Z)-icosatrienoic acidChEBI
14S,15R-EETLIPID MAPS
14S,15R-EpETrELIPID MAPS
14S,15R-epoxy-5Z,8Z,11Z-eicosatrienoic acidLIPID MAPS
Manual XrefsDatabases
LMFA03080013LIPID MAPS
Registry NumbersSources
Reaxys:4703442Reaxys
Citations